Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Esplanade Ventures is a venture capital firm established in 2019 and based in Canada, dedicated to advancing digital health innovation. Founded by a team of healthcare operators, founders, and investors, the firm boasts over 100 years of collective experience in the healthcare sector. Esplanade Ventures primarily invests in technology companies that are transforming healthcare delivery across the United States and Canada.
Currently, the firm is active in the venture capital space, focusing on early-stage and high-growth companies. While specific metrics such as assets under management (AUM) and fund size have not been disclosed, Esplanade Ventures is recognized for its concentrated approach to digital health technologies. The firm operates from two offices located in Toronto and Montréal, Canada.
Esplanade Ventures invests in early-stage and high-growth companies, particularly those developing digital health solutions. The firm has a strong preference for AI-enabled technologies, which aligns with its mission to enhance healthcare delivery. Esplanade Ventures typically engages in Seed to Series A rounds, with selective investments in Series B rounds. This investment strategy allows the firm to support companies that are commercializing innovative solutions in North America.
Notably, Esplanade Ventures does not invest in invasive devices or biotech, ensuring a focused approach on digital health technologies. The firm seeks to partner with companies that are redefining access, efficiency, and outcomes in healthcare, making it a valuable ally for startups in the digital health sector.
Esplanade Ventures supports a diverse range of companies that are redefining access, efficiency, and outcomes in healthcare. While specific names and descriptions of portfolio companies were not provided, the firm is known for its commitment to investing in companies that are at the forefront of digital health innovation. This includes startups that leverage AI technologies to improve healthcare delivery and patient outcomes.
By concentrating on early-stage companies, Esplanade Ventures positions itself to play a significant role in the growth of the digital health sector across North America. The firm’s portfolio reflects its strategic focus on enhancing healthcare through technology, although detailed information about individual companies remains undisclosed.
Dr. Sheldon Elman, MD - Co-Founder & Chairman. Dr. Elman has extensive experience in healthcare operations and has played a pivotal role in shaping the firm's investment strategy.
Stuart M. Elman - Co-Founder. Stuart brings a wealth of knowledge in healthcare investment and entrepreneurship, contributing to the firm's strategic direction.
Josh Blair - Venture Partner. Josh has a background in technology and healthcare, focusing on identifying promising investment opportunities.
Ella Seitz - Managing Partner. Ella oversees the firm's operations and investment processes, leveraging her expertise in venture capital.
Alexandre Nossovskoi - Principal. Alexandre is involved in sourcing and evaluating potential investments, with a keen interest in digital health technologies.
Timothy Sung - Associate. Timothy supports the investment team in due diligence and portfolio management.
Kavuchaljan Ganesathasan - VP Finance. Kavuchaljan manages the financial operations of the firm, ensuring sound fiscal practices.
Dr. Yosef Berlyand, MD - Advisor. Dr. Berlyand provides insights into healthcare trends and investment opportunities, enhancing the firm's strategic approach.
To pitch Esplanade Ventures, founders should use the application portal available on their website at esplanadeventures.com. It is recommended to include a comprehensive deck that outlines the business model, technology, market opportunity, and team qualifications. Response times may vary, so founders should be prepared for potential follow-up discussions.
As of October 2023, Esplanade Ventures continues to focus on digital health innovation, actively seeking investment opportunities in early-stage companies. The firm has not publicly announced any recent investments or exits, but its commitment to enhancing healthcare delivery remains strong.
Esplanade Ventures has been promoting its investment strategy through its website, emphasizing its focus on AI-enabled technologies in the digital health sector. However, no recent blog posts or updates have been detected that indicate ongoing engagement or thought leadership in the sector.
What are Esplanade Ventures' investment criteria?
Esplanade Ventures focuses on early-stage and high-growth companies, particularly those developing digital health solutions with a preference for AI-enabled technologies. The firm typically invests in Seed to Series A rounds, with selective Series B investments.
How can I apply or pitch to Esplanade Ventures?
Founders can pitch their ideas through the firm's website at esplanadeventures.com. It is advisable to include a clear description of the technology, market potential, and team background in the pitch deck.
What makes Esplanade Ventures different from other VC firms?
Esplanade Ventures is distinguished by its exclusive focus on digital health innovation and AI technologies. The firm does not invest in invasive devices or biotech, allowing it to concentrate its resources on enhancing healthcare delivery.
What is the geographic scope of Esplanade Ventures?
The firm primarily invests in companies that are commercializing their solutions in North America, specifically in the United States and Canada.
What type of post-investment involvement can founders expect?
While specific details about post-investment involvement are not disclosed, Esplanade Ventures is known for providing support to its portfolio companies, leveraging its extensive experience in healthcare operations and technology.
What is the typical check size for investments?
Esplanade Ventures typically engages in Seed to Series A rounds, but specific check sizes have not been disclosed. Founders are encouraged to present their funding needs during the pitch process.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.